{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:31:34Z","timestamp":1790605894137,"version":"4.1.0"},"reference-count":134,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR2046"],"award-info":[{"award-number":["NIHR2046"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.berh.2021.101694","type":"journal-article","created":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T07:06:40Z","timestamp":1622963200000},"page":"101694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Pathogenesis of psoriatic arthritis"],"prefix":"10.1016","volume":"35","author":[{"given":"Carmel","family":"Stober","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A\u00a0systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.berh.2021.101694_bib2","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1136\/annrheumdis-2015-207980","article-title":"Incidence and predictors for cardiovascular events in patients with psoriatic arthritis","volume":"75","author":"Eder","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jaad.2015.05.001","article-title":"Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis","volume":"73","author":"Villani","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"suppl 10","key":"10.1016\/j.berh.2021.101694_bib4","article-title":"Vascular endothelial and inflammatory differences in psoriasis and psoriatic arthritis patients [abstract]","volume":"70","author":"Gashick","year":"2018","journal-title":"Arthritis Rheum"},{"issue":"suppl 10","key":"10.1016\/j.berh.2021.101694_bib5","article-title":"Adipose tissue inflammation in psoriatic arthritis: overexpression of a wide array of inflammatory mediators and associations with disease and treatment characteristics [abstract]","volume":"70","author":"Yun","year":"2018","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib6","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/art.38995","article-title":"Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis","volume":"67","author":"Belasco","year":"2015","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.berh.2021.101694_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41584-020-00507-9","article-title":"Applying precision medicine to unmet clinical needs in psoriatic disease","volume":"16","author":"Jadon","year":"2020","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"Supplement 2","key":"10.1016\/j.berh.2021.101694_bib9","first-page":"OPO113","article-title":"Histological and molecular portrait of the synovial tissue in early treatment-na\u00efve psoriatic arthritis in comparison with rheumatoid arthritis [ABSTRACT OP0113]","volume":"78","author":"Nerviani","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2021.101694_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3899\/jrheum.190118","article-title":"Proceedings of the 2018 GRAPPA collaborative Research Network meeting","volume":"95","author":"Jadon","year":"2019","journal-title":"J\u00a0Rheumatol Suppl"},{"key":"10.1016\/j.berh.2021.101694_bib11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3899\/jrheum.180141","article-title":"Proceedings of the 2017 GRAPPA collaborative Research Network meeting","volume":"94","author":"Jadon","year":"2018","journal-title":"J\u00a0Rheumatol Suppl"},{"key":"10.1016\/j.berh.2021.101694_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3899\/jrheum.200123","article-title":"Proceedings of the 2019 GRAPPA collaborative Research Network meeting","volume":"96","author":"Waxman","year":"2020","journal-title":"J\u00a0Rheumatol Suppl"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib13","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.2008.089367","article-title":"Familial aggregation of psoriatic arthritis","volume":"68","author":"Chandran","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archderm.1994.01690020082014","article-title":"The genetics of psoriasis","volume":"130","author":"Elder","year":"1994","journal-title":"Arch Dermatol"},{"issue":"11","key":"10.1016\/j.berh.2021.101694_bib15","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/rheumatology\/kep243","article-title":"A\u00a0strong heritability of psoriatic arthritis over four generations--the Reykjavik Psoriatic Arthritis Study","volume":"48","author":"Karason","year":"2009","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/ard.32.3.181","article-title":"Familial occurrence of psoriatic arthritis","volume":"32","author":"Moll","year":"1973","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2021.101694_bib17","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/rheumatology\/keh589","article-title":"Recurrence risk for psoriasis and psoriatic arthritis within sibships","volume":"44","author":"Myers","year":"2005","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib18","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.33415","article-title":"HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype","volume":"64","author":"Winchester","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/ard.2011.155044","article-title":"Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis","volume":"71","author":"Eder","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/annrheumdis-2014-205461","article-title":"Certain class I HLA alleles and haplotypes implicated in susceptibility play a role in determining specific features of the psoriatic arthritis phenotype","volume":"75","author":"Haroon","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2021.101694_bib21","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.1038\/ncomms7046","article-title":"Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis","volume":"6","author":"Bowes","year":"2015","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.berh.2021.101694_bib22","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/annrheumdis-2014-207187","article-title":"PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus","volume":"74","author":"Bowes","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2021.101694_bib23","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.ajhg.2015.10.019","article-title":"Genome-wide association analysis of psoriatic arthritis and cutaneous psoriasis reveals differences in their genetic architecture","volume":"97","author":"Stuart","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.berh.2021.101694_bib24","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.39261","article-title":"Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid","volume":"67","author":"Leijten","year":"2015","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.4049\/jimmunol.1700596","article-title":"Cutting edge: homeostasis of innate lymphoid cells is imbalanced in psoriatic arthritis","volume":"200","author":"Soare","year":"2018","journal-title":"J\u00a0Immunol"},{"issue":"9","key":"10.1016\/j.berh.2021.101694_bib26","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","article-title":"The biology and functional importance of MAIT cells","volume":"20","author":"Godfrey","year":"2019","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib27","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/jgh.13242","article-title":"MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis","volume":"31","author":"Haga","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cei.12277","article-title":"Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases","volume":"176","author":"Serriari","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2220\/biomedres.38.111","article-title":"Possible involvement of mucosal-associated invariant T cells in the progression of inflammatory bowel diseases","volume":"38","author":"Tominaga","year":"2017","journal-title":"Biomed Res"},{"issue":"12","key":"10.1016\/j.berh.2021.101694_bib30","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1136\/annrheumdis-2015-208902","article-title":"IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis","volume":"75","author":"Gracey","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.berh.2021.101694_bib31","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3899\/jrheum.151133","article-title":"Involvement of mucosal-associated invariant T cells in ankylosing spondylitis","volume":"43","author":"Hayashi","year":"2016","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.berh.2021.101694_bib32","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.3389\/fimmu.2018.01610","article-title":"Increased IL-22- and IL-17a-producing mucosal-associated invariant T cells in the peripheral blood of patients with ankylosing spondylitis","volume":"9","author":"Toussirot","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib33","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/art.38376","article-title":"Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression","volume":"66","author":"Menon","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2021.101694_bib34","doi-asserted-by":"crossref","first-page":"154855","DOI":"10.1016\/j.cyto.2019.154855","article-title":"Functional significance of MAIT cells in psoriatic arthritis","volume":"125","author":"Raychaudhuri","year":"2020","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41467-018-07911-6","article-title":"RORgammat inhibition selectively targets IL-17 producing iNKT and gammadelta-T cells enriched in Spondyloarthritis patients","volume":"10","author":"Venken","year":"2019","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ni.2025","article-title":"Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22","volume":"12","author":"Sonnenberg","year":"2011","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/art.33396","article-title":"Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis","volume":"64","author":"Noordenbos","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib38","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar1864","article-title":"Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis","volume":"8","author":"Jongbloed","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib39","first-page":"374","article-title":"Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity?","volume":"34","author":"Candia","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib40","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.4049\/jimmunol.173.4.2815","article-title":"Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis","volume":"173","author":"Lande","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib41","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/s41467-020-18513-6","article-title":"Single-cell sequencing reveals clonal expansions of pro-inflammatory synovial CD8 T cells expressing tissue-homing receptors in psoriatic arthritis","volume":"11","author":"Penkava","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12967-019-2128-4","article-title":"Targeting of tolerogenic dendritic cells to heat-shock proteins in inflammatory arthritis","volume":"17","author":"Spiering","year":"2019","journal-title":"J\u00a0Transl Med"},{"issue":"6","key":"10.1016\/j.berh.2021.101694_bib43","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2","article-title":"Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis","volume":"43","author":"Danning","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib44","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/art.24406","article-title":"Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis","volume":"60","author":"Vandooren","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/path.1044","article-title":"Macrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathy","volume":"196","author":"Baeten","year":"2002","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib46","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/art.20174","article-title":"Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis","volume":"50","author":"Baeten","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2021.101694_bib47","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/art.23512","article-title":"Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-gamma dysregulation","volume":"58","author":"Smith","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2021.101694_bib48","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fimmu.2020.01070","article-title":"Human monocyte subset distinctions and function: insights from gene expression analysis","volume":"11","author":"Cormican","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib49","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/ar4317","article-title":"Th17 and Th22 cells in psoriatic arthritis and psoriasis","volume":"15","author":"Benham","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/art.41156","article-title":"Polyfunctional, Proinflammatory, Tissue-resident memory phenotype and function of synovial interleukin-17A+CD8+ T cells in psoriatic arthritis","volume":"72","author":"Steel","year":"2020","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.berh.2021.101694_bib51","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1136\/ard.2005.050963","article-title":"Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment","volume":"65","author":"van Kuijk","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib52","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/annrheumdis-2018-214138","article-title":"Association of synovial tissue polyfunctional T-cells with DAPSA in psoriatic arthritis","volume":"78","author":"Wade","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib53","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/ar3781","article-title":"Functional role of IL-22 in psoriatic arthritis","volume":"14","author":"Mitra","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib54","first-page":"488","article-title":"Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies","volume":"56","author":"El-Zayadi","year":"2017","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib55","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/art.33446","article-title":"Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cyto.2012.06.316","article-title":"IL-22 induced cell proliferation is regulated by PI3K\/Akt\/mTOR signaling cascade","volume":"60","author":"Mitra","year":"2012","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib57","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.20090246","article-title":"IL-9 as a mediator of Th17-driven inflammatory disease","volume":"206","author":"Nowak","year":"2009","journal-title":"J\u00a0Exp Med"},{"issue":"31","key":"10.1016\/j.berh.2021.101694_bib58","doi-asserted-by":"crossref","first-page":"12885","DOI":"10.1073\/pnas.0812530106","article-title":"IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells","volume":"106","author":"Elyaman","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib59","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1002\/art.39649","article-title":"Interleukin-9 overexpression and Th9 polarization characterize the inflamed gut, the synovial tissue, and the peripheral blood of patients with psoriatic arthritis","volume":"68","author":"Ciccia","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/MAJ.0b013e31820f8b29","article-title":"Structural bone changes in spondyloarthritis: mechanisms, clinical impact and therapeutic considerations","volume":"341","author":"Schett","year":"2011","journal-title":"Am J Med Sci"},{"issue":"12","key":"10.1016\/j.berh.2021.101694_bib61","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J\u00a0Exp Med"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2016-209709","volume":"76","author":"Mease","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib63","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/art.39685","article-title":"Brief report: secukinumab provides significant and sustained inhibition of joint structural damage in a phase III study of active psoriatic arthritis","volume":"68","author":"van der Heijde","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2021.101694_bib64","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/annrheumdis-2013-204741","volume":"73","author":"Kavanaugh","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2021.101694_bib65","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1002\/art.21306","article-title":"Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial","volume":"52","author":"Mease","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.berh.2021.101694_bib66","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/art.20335","article-title":"Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression","volume":"50","author":"Mease","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib67","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/art.22805","article-title":"Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: results from the induction and maintenance psoriatic arthritis clinical trial 2","volume":"56","author":"van der Heijde","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib68","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.4049\/jimmunol.181.8.5720","article-title":"IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice","volume":"181","author":"Quinn","year":"2008","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3899\/jrheum.140223","article-title":"Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy","volume":"42","author":"Jadon","year":"2015","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib70","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.27231","article-title":"Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis","volume":"62","author":"Daoussis","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib71","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.intimp.2014.05.031","article-title":"Evaluation of circulating levels of inflammatory and bone formation markers in axial spondyloarthritis","volume":"21","author":"de Andrade","year":"2014","journal-title":"Int Immunopharm"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib72","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/annrheumdis-2011-200216","article-title":"High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis","volume":"71","author":"Heiland","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2021.101694_bib73","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3899\/jrheum.131199","article-title":"Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis","volume":"41","author":"Klingberg","year":"2014","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib74","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s00296-011-1981-0","article-title":"Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy","volume":"32","author":"Kwon","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.berh.2021.101694_bib75","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2474-13-191","article-title":"Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis","volume":"13","author":"Taylan","year":"2012","journal-title":"BMC Muscoskel Disord"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib76","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3899\/jrheum.100089","article-title":"Circulating Dickkopf-1 is correlated with bone erosion and inflammation in rheumatoid arthritis","volume":"38","author":"Wang","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"9","key":"10.1016\/j.berh.2021.101694_bib77","first-page":"1527","article-title":"Serum functional dickkopf-1 levels are inversely correlated with radiographic severity of ankylosing spondylitis","volume":"60","author":"Yucong","year":"2014","journal-title":"Clin Lab"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib78","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13075-017-1417-7","article-title":"Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study","volume":"19","author":"Jadon","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib79","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib80","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/annrheumdis-2016-209853","article-title":"Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis","volume":"76","author":"Jadon","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2021.101694_bib81","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.38070","article-title":"The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis","volume":"65","author":"Haroon","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib82","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/ard.30.3.213","article-title":"Enthesopathy of rheumatoid and ankylosing spondylitis","volume":"30","author":"Ball","year":"1971","journal-title":"Ann Rheum Dis"},{"issue":"Pt 5","key":"10.1016\/j.berh.2021.101694_bib83","first-page":"503","article-title":"The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites","volume":"199","author":"Benjamin","year":"2001","journal-title":"J\u00a0Anat"},{"issue":"10","key":"10.1016\/j.berh.2021.101694_bib84","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1002\/art.20566","article-title":"The \"enthesis organ\" concept: why enthesopathies may not present as focal insertional disorders","volume":"50","author":"Benjamin","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4 Suppl 55","key":"10.1016\/j.berh.2021.101694_bib85","first-page":"S50","article-title":"Entheseal involvement","volume":"27","author":"Ma","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib86","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.1300274","article-title":"Synovial fibroblasts directly induce Th17 pathogenicity via the cyclooxygenase\/prostaglandin E2 pathway, independent of IL-23","volume":"191","author":"Paulissen","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"7","key":"10.1016\/j.berh.2021.101694_bib87","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-gammat+ CD3+CD4-CD8- entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.berh.2021.101694_bib88","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2018-214944","article-title":"Identification of myeloid cells in the human enthesis as the main source of local IL-23 production","volume":"78","author":"Bridgewood","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.berh.2021.101694_bib89","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.39732","article-title":"Interleukin-23-Dependent gamma\/delta T cells produce interleukin-17 and accumulate in the enthesis, aortic valve, and ciliary body in mice","volume":"68","author":"Reinhardt","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2021.101694_bib90","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/art.40150","article-title":"Brief report: group 3 innate lymphoid cells in human enthesis","volume":"69","author":"Cuthbert","year":"2017","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.berh.2021.101694_bib91","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","article-title":"Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study","volume":"77","author":"Baeten","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.berh.2021.101694_bib92","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204782","article-title":"IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis","volume":"74","author":"Adamopoulos","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib93","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4049\/jimmunol.1003986","article-title":"IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass","volume":"187","author":"Adamopoulos","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"9","key":"10.1016\/j.berh.2021.101694_bib94","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1182\/blood-2005-09-010116","article-title":"An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals","volume":"109","author":"Yu","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib95","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1038\/s41467-018-06933-4","article-title":"Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis","volume":"9","author":"Cambre","year":"2018","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib96","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/annrheumdis-2013-203643","article-title":"Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells","volume":"73","author":"Jacques","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2021.101694_bib97","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/gene.2009.51","article-title":"Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes","volume":"10","author":"Quaranta","year":"2009","journal-title":"Gene Immun"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib98","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.ajpath.2010.12.017","article-title":"Psoriasis risk genes of the late cornified envelope-3 group are distinctly expressed compared with genes of other LCE groups","volume":"178","author":"Bergboer","year":"2011","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib99","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20050500","article-title":"Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production","volume":"202","author":"Nestle","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","article-title":"CD49a expression defines tissue-resident CD8(+) T cells poised for cytotoxic function in human skin","volume":"46","author":"Cheuk","year":"2017","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib101","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1515\/cclm-2012-0251","article-title":"Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease","volume":"51","author":"Eissa","year":"2013","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib102","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2353\/ajpath.2008.080088","article-title":"Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis","volume":"173","author":"Elias","year":"2008","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.berh.2021.101694_bib103","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/jid.2008.375","article-title":"Regulatory T cells control VEGF-dependent skin inflammation","volume":"129","author":"Teige","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"issue":"Suppl 10","key":"10.1016\/j.berh.2021.101694_bib104","first-page":"1","article-title":"ACR convergence 2020 abstract supplement: a Delphi consensus study to standardize terminology for the pre-clinical phase of psoriatic arthritis","volume":"72","author":"Perez-Chada","year":"2020","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib105","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/acr.20401","article-title":"Incidence of arthritis in a prospective cohort of psoriasis patients","volume":"63","author":"Eder","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib106","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/art.39494","article-title":"The incidence and risk factors for psoriatic arthritis in patients with psoriasis: a prospective cohort study","volume":"68","author":"Eder","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib107","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/acr.20496","article-title":"Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis","volume":"63","author":"Eder","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib108","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib109","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/rheumatology\/kes324","article-title":"Prevalence and treatment patterns of psoriatic arthritis in the UK","volume":"52","author":"Ogdie","year":"2013","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1346-8138.2009.00745.x","article-title":"Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis","volume":"37","author":"Tey","year":"2010","journal-title":"J\u00a0Dermatol"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib111","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/annrheumdis-2011-201273","article-title":"Obesity and risk of incident psoriatic arthritis in US women","volume":"71","author":"Li","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib112","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: a population-based study","volume":"71","author":"Love","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.berh.2021.101694_bib113","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archdermatol.2010.141","article-title":"Obesity in early adulthood as a risk factor for psoriatic arthritis","volume":"146","author":"Soltani-Arabshahi","year":"2010","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib114","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s10067-013-2436-7","article-title":"Can traumatic injury trigger psoriatic arthritis? A review of the literature","volume":"33","author":"Hsieh","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib115","first-page":"277","article-title":"Clinical, laboratory and immunogenetic aspects of post-traumatic psoriatic arthritis: a study of 25 patients","volume":"16","author":"Punzi","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib116","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/annrheumdis-2016-209334","article-title":"Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis","volume":"76","author":"Thorarensen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.berh.2021.101694_bib117","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","article-title":"Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype","volume":"17","author":"FitzGerald","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.berh.2021.101694_bib118","first-page":"2273","article-title":"The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects","volume":"22","author":"Mielants","year":"1995","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2021.101694_bib119","first-page":"1241","article-title":"Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms","volume":"27","author":"Scarpa","year":"2000","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.38892","article-title":"Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease","volume":"67","author":"Scher","year":"2015","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.berh.2021.101694_bib121","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis","volume":"111","author":"Ritchlin","year":"2003","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.berh.2021.101694_bib122","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/art.39800","article-title":"Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis","volume":"68","author":"Abji","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2021.101694_bib123","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.23298","article-title":"Differentiating psoriatic arthritis from psoriasis without psoriatic arthritis using novel serum biomarkers","volume":"70","author":"Cretu","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1559-0275-12-1","article-title":"Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers","volume":"12","author":"Cretu","year":"2015","journal-title":"Clin Proteonomics"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib125","first-page":"1502","article-title":"Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses","volume":"21","author":"Espinoza","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.berh.2021.101694_bib126","first-page":"1507","article-title":"Fibroblast function in psoriatic arthritis. II. Increased expression of beta platelet derived growth factor receptors and increased production of growth factor and cytokines","volume":"21","author":"Espinoza","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.berh.2021.101694_bib127","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000471","article-title":"Synovial fibroblasts in 2017","volume":"3","author":"Ospelt","year":"2017","journal-title":"RMD Open"},{"issue":"4","key":"10.1016\/j.berh.2021.101694_bib128","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11926-012-0259-1","article-title":"Altered bone biology in psoriatic arthritis","volume":"14","author":"Rahimi","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.berh.2021.101694_bib129","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3389\/fimmu.2019.00679","article-title":"Osteoimmunology of bone loss in inflammatory rheumatic diseases","volume":"10","author":"Coury","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.berh.2021.101694_bib130","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/jemt.10374","article-title":"Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities","volume":"61","author":"Delaisse","year":"2003","journal-title":"Microsc Res Tech"},{"key":"10.1016\/j.berh.2021.101694_bib131","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage","year":"2006","journal-title":"Front Biosci"},{"issue":"1","key":"10.1016\/j.berh.2021.101694_bib132","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13238-010-0002-5","article-title":"The role of ADAMTSs in arthritis","volume":"1","author":"Lin","year":"2010","journal-title":"Protein Cell"},{"issue":"11","key":"10.1016\/j.berh.2021.101694_bib133","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-019-0285-8","article-title":"Bedside to bench: defining the immunopathogenesis of psoriatic arthritis","volume":"15","author":"Bravo","year":"2019","journal-title":"Nat Rev Rheumatol"},{"issue":"9997","key":"10.1016\/j.berh.2021.101694_bib134","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","volume":"386","author":"Boehncke","year":"2015","journal-title":"Psoriasis. Lancet."}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422100036X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152169422100036X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:21:24Z","timestamp":1761499284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152169422100036X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":134,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S152169422100036X"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2021.101694","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of psoriatic arthritis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2021.101694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101694"}}